Twist Bioscience Corporation (TWST)
NASDAQ: TWST · Real-Time Price · USD
32.04
+1.49 (4.88%)
At close: Oct 15, 2025, 4:00 PM EDT
32.32
+0.28 (0.87%)
Pre-market: Oct 16, 2025, 8:06 AM EDT
Twist Bioscience Stock Forecast
Stock Price Forecast
The 9 analysts that cover Twist Bioscience stock have a consensus rating of "Buy" and an average price target of $48.56, which forecasts a 51.56% increase in the stock price over the next year. The lowest target is $33 and the highest is $62.
Price Target: $48.56 (+51.56%)
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for Twist Bioscience stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | May '25 | Jun '25 | Jul '25 | Aug '25 | Sep '25 | Oct '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 3 | 3 | 3 |
| Buy | 5 | 5 | 5 | 5 | 5 | 5 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 2 | 2 | 2 | 2 | 2 | 1 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 10 | 10 | 10 | 10 | 10 | 9 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Evercore ISI Group | Evercore ISI Group | Buy Maintains $46 → $42 | Buy | Maintains | $46 → $42 | +31.09% | Oct 7, 2025 |
| Barclays | Barclays | Buy Maintains $45 → $40 | Buy | Maintains | $45 → $40 | +24.84% | Oct 2, 2025 |
| Goldman Sachs | Goldman Sachs | Strong Buy Maintains $55 → $48 | Strong Buy | Maintains | $55 → $48 | +49.81% | May 6, 2025 |
| Guggenheim | Guggenheim | Strong Buy Reiterates $50 | Strong Buy | Reiterates | $50 | +56.05% | May 6, 2025 |
| Baird | Baird | Buy Maintains $54 → $44 | Buy | Maintains | $54 → $44 | +37.33% | May 6, 2025 |
Financial Forecast
Revenue This Year
382.16M
from 312.97M
Increased by 22.11%
Revenue Next Year
449.04M
from 382.16M
Increased by 17.50%
EPS This Year
-1.48
from -3.60
EPS Next Year
-1.49
from -1.48
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 394.8M | 471.5M | ||||
| Avg | 382.2M | 449.0M | ||||
| Low | 365.3M | 420.5M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 26.1% | 23.4% | ||||
| Avg | 22.1% | 17.5% | ||||
| Low | 16.7% | 10.0% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | -1.23 | -0.92 | |
| Avg | -1.48 | -1.49 | |
| Low | -2.72 | -2.35 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | - | - | |
| Avg | - | - | |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.